The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Åke Borg

Åke Borg

Principal investigator

Åke Borg

Molecular characterization of melanoma cases in denmark suspected of genetic predisposition.

Author

  • Karin A W Wadt
  • Lauren G Aoude
  • Lotte Krogh
  • Lone Sunde
  • Anders Bojesen
  • Karen Grønskov
  • Nine Wartacz
  • Jakob Ek
  • Morten Tolstrup-Andersen
  • Mette Klarskov-Andersen
  • Åke Borg
  • Steffen Heegaard
  • Jens F Kiilgaard
  • Thomas V O Hansen
  • Kerenaftali Klein
  • Göran B Jönsson
  • Krzysztof T Drzewiecki
  • Morten Dunø
  • Nicholas K Hayward
  • Anne-Marie Gerdes
Show all

Summary, in English

Both environmental and host factors influence risk of cutaneous melanoma (CM), and worldwide, the incidence varies depending on constitutional determinants of skin type and pigmentation, latitude, and patterns of sun exposure. We performed genetic analysis of CDKN2A, CDK4, BAP1, MC1R, and MITFp.E318K in Danish high-risk melanoma cases and found CDKN2A germline mutations in 11.3% of CM families with three or more affected individuals, including four previously undescribed mutations. Rare mutations were also seen in CDK4 and BAP1, while MC1R variants were common, occurring at more than twice the frequency compared to Danish controls. The MITF p.E318K variant similarly occurred at an approximately three-fold higher frequency in melanoma cases than controls. To conclude, we propose that mutation screening of CDKN2A and CDK4 in Denmark should predominantly be performed in families with at least 3 cases of CM. In addition, we recommend that testing of BAP1 should not be conducted routinely in CM families but should be reserved for families with CM and uveal melanoma, or mesothelioma.

Department/s

  • Breastcancer-genetics
  • BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation

Publishing year

2015

Language

English

Publication/Series

PLoS ONE

Volume

10

Issue

3

Document type

Journal article

Publisher

Public Library of Science (PLoS)

Topic

  • Cancer and Oncology

Status

Published

ISBN/ISSN/Other

  • ISSN: 1932-6203